Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction

Eitemau Tebyg

• Non–Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection
  gan: Saccucci, Mónica, et al.
  Cyhoeddwyd: (2018)
• Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women
  gan: Spinner, Chelse, et al.
  Cyhoeddwyd: (2019)
• Vaccine-Type Human Papillomavirus and Evidence of Herd Protection After Vaccine Introduction
  gan: Kahn, Jessica A., et al.
  Cyhoeddwyd: (2012)
• Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction
  gan: Widdice, Lea E., et al.
  Cyhoeddwyd: (2019)
• Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community
  gan: Kahn, Jessica A., et al.
  Cyhoeddwyd: (2016)